Ferrari R, Ford I, Fox K, Challeton JP, et al. Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial. Lancet 2020 Aug 28. pii: S0140-6736(20)31790.
PMID: 32877651